Leadership Overview
Fresenius Kabi has 7 executives leading key functions including strategy, financial oversight, operational management, and regional pharmaceutical development.
Committed to advancing patient care through specialized infusion and clinical nutrition, Fresenius Kabi drives global health outcomes by delivering essential medicines and innovative medical technologies to healthcare providers worldwide.
Committed to advancing patient care through specialized infusion and clinical nutrition, Fresenius Kabi drives global health outcomes by delivering essential medicines and innovative medical technologies to healthcare providers worldwide.
Leadership Roles at Fresenius Kabi
Anastasia Roulita - Secretary & Chief Executive Officer & Sales Director
Anastasia Roulita, the Secretary & Chief Executive Officer & Sales Director at Fresenius Kabi, directs the overarching corporate strategy and global sales initiatives. Overseeing the integration of infusion and clinical nutrition portfolios, the Chief Executive Officer ensures alignment between market demand and pharmaceutical production. This leadership role involves managing complex governance requirements while driving revenue growth across international markets. By optimizing sales channels and fostering partnerships with healthcare institutions, Anastasia Roulita directly impacts the company's market position. Roulita maintains rigorous standards for corporate compliance and operational transparency. Through the coordination of cross-functional teams, the Sales Director secures long-term stability for the organization. This executive leadership focuses on expanding the reach of life-saving technologies, ensuring that clinical nutrition solutions remain accessible to patients globally. Roulita consistently evaluates market trends to refine the strategic direction of the firm.
Ahmed Kammoun - Chief Financial Officer
Ahmed Kammoun, the Chief Financial Officer at Fresenius Kabi, manages the global financial health and capital allocation strategies for the organization. Overseeing fiscal planning, the Chief Financial Officer ensures the efficient distribution of resources across infusion and transfusion business units. This leadership role involves maintaining robust financial reporting standards and supporting the Board with data-driven insights for long-term investment decisions. By optimizing cost structures and monitoring global economic fluctuations, Ahmed Kammoun directly impacts the company's profitability and growth trajectory. Kammoun coordinates with regional finance leads to ensure consistency in financial performance across diverse international markets. Through the implementation of advanced financial modeling, the Chief Financial Officer mitigates operational risks and enhances shareholder value. This executive leadership supports the broader mission of delivering essential medicines by securing the necessary capital for research, development, and manufacturing excellence.
Christian Mattis - Chief Financial Officer, Medtech NAM
Christian Mattis, the Chief Financial Officer, Medtech NAM at Fresenius Kabi, manages the financial operations for the medical technology division within the North American market. Overseeing regional budgeting and financial planning, the Chief Financial Officer, Medtech NAM ensures that resource allocation supports the growth of infusion and transfusion technologies. This leadership role involves analyzing regional market performance and providing strategic financial guidance to the North American leadership team. By optimizing regional cost management and ensuring compliance with local financial regulations, Christian Mattis directly impacts the company's competitive standing in the North American healthcare sector. Mattis collaborates with global finance leaders to align regional objectives with the broader corporate strategy. Through the rigorous monitoring of financial KPIs, the Chief Financial Officer, Medtech NAM secures the fiscal health of the division. This executive leadership drives the financial success of medical technology initiatives across the continent.
Alex Garini - Executive Vice President & Chief Financial Officer
Alex Garini, the Executive Vice President & Chief Financial Officer at Fresenius Kabi, directs the global financial strategy and corporate development initiatives. Overseeing the financial architecture of the company, the Executive Vice President & Chief Financial Officer ensures that capital investments align with the long-term goals of the infusion and clinical nutrition business. This leadership role involves managing investor relations and overseeing the financial health of the entire organization. By optimizing the balance sheet and driving strategic financial planning, Alex Garini directly impacts the company's ability to innovate and expand its global footprint. Garini coordinates with the C-suite to evaluate potential acquisitions and market opportunities. Through the oversight of financial risk management, the Executive Vice President & Chief Financial Officer maintains the stability of the firm. This executive leadership supports the company's mission by ensuring that financial resources are effectively utilized to advance patient care.
Kaushal Gupta - Chief Financial Officer, of Fresenius Kabi (South, Asia, India)
Kaushal Gupta, the Chief Financial Officer, of Fresenius Kabi (South, Asia, India) at Fresenius Kabi, manages the financial operations across the South Asian and Indian markets. Overseeing regional fiscal strategy, the Chief Financial Officer, of Fresenius Kabi (South, Asia, India) ensures that financial resources support the distribution of infusion and clinical nutrition products in these high-growth regions. This leadership role involves navigating complex regulatory environments and optimizing regional financial performance. By implementing robust accounting practices and managing local investment portfolios, Kaushal Gupta directly impacts the company's growth in the South Asian healthcare sector. Gupta collaborates with regional operational leads to ensure that financial targets align with market expansion goals. Through the diligent oversight of regional budgets, the Chief Financial Officer, of Fresenius Kabi (South, Asia, India) secures the financial sustainability of the business. This executive leadership drives the company's success in these critical emerging markets.
Rakesh Patel - Chief Operating Officer
Rakesh Patel, the Chief Operating Officer at Fresenius Kabi, directs the global manufacturing and supply chain operations for infusion and clinical nutrition products. Overseeing the production facilities, the Chief Operating Officer ensures that quality standards meet the rigorous demands of the pharmaceutical industry. This leadership role involves streamlining logistics to guarantee the timely delivery of essential medical technologies to healthcare providers. By optimizing manufacturing processes and enhancing operational efficiency, Rakesh Patel directly impacts the company's ability to scale production in response to global health needs. Patel coordinates with technical teams to integrate new technologies into existing workflows. Through the management of complex supply chains, the Chief Operating Officer maintains the reliability of the product portfolio. This executive leadership focuses on operational excellence, ensuring that the company remains a leader in the production of life-saving medical solutions across all international markets.
Scott Meacham - President, Pharmaceuticals (USA)
Scott Meacham, the President, Pharmaceuticals (USA) at Fresenius Kabi, directs the pharmaceutical business operations within the United States. Overseeing the development and commercialization of infusion and clinical nutrition medicines, the President, Pharmaceuticals (USA) ensures that the product portfolio meets the needs of American healthcare providers. This leadership role involves managing the go-to-market strategy and fostering relationships with key stakeholders in the US market. By optimizing the pharmaceutical supply chain and driving sales growth, Scott Meacham directly impacts the company's market share in the United States. Meacham coordinates with regulatory and clinical teams to ensure the successful launch of new pharmaceutical products. Through the strategic management of the US pharmaceutical division, the President, Pharmaceuticals (USA) maintains the company's reputation for quality and innovation. This executive leadership focuses on delivering essential medicines to patients across the country, ensuring that the company remains a trusted partner in the US healthcare system.
Explore Leadership Teams in Manufacturing
Bayer is a global enterprise with core competencies in the life science fields of health care and agriculture, headquartered in Leverkusen, Germany. The company operates through three divisions: Pharmaceuticals, which focuses on prescription products for cardiology, women's health, oncology, hematology, and ophthalmology; Consumer Health, a supplier of self-care products across dermatology, nutrition, and pain management; and Crop Science, which provides seeds, biotechnology traits, and crop protection products. Bayer serves patients, consumers, and farmers globally, delivering value through a combination of innovative medicines, self-care brands, and digital farming tools designed to improve human health and support sustainable food security.
Company Leadership RN
CV
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Company Leadership CD
NB
ES
SS
Tolmar Pharmaceuticals is a fully integrated pharmaceutical company focused on the innovative development, manufacturing, and commercialization of specialty pharmaceuticals across multiple therapeutic areas, including Urology. Tolmar global headquarters, product development and manufacturing facilities are based in Northern Colorado, while North America commercial headquarters is based in Buffalo Grove, Illinois.
Company Leadership AD
JL
SG
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions.
Company Leadership KW
SH
CH
Frequently Asked Questions Regarding Fresenius Kabi Top Executives and Leadership Team
Unlock more people and company data
